1 May
2020

How AI is set to disrupt pharma IP business models

Increasing numbers of patent applications prove that AI is having a profound impact on the pharmaceutical industry. BenevolentAI’s Gareth Jones identifies numerous arguments for and against amending inventorship rules

Gareth Jones

Vice president of intellectual property | BenevolentAI